An assessment of new product development in the Irish pharmaceutical industry

Abstract

In today's competitive drug development environment, Irish pharmaceutical companies are moving towards more knowledge base activities. These companies must focus on new product development (NPD) firstly to remain competitive and ultimately to survive. This work assesses the current NPD process in the Irish pharmaceutical industry by examining models from literature and quantitative research in the form of a survey. Integration and communication of project management and NPD systems is critical. The requirement for improvements in information flow, performance management, risk management and the development of a cohesive costing system is highlighted.